DSpace@İnönü

Yazar "Ucar, MA" için listeleme

Yazar "Ucar, MA" için listeleme

Sırala: Sıra: Sonuçlar:

  • THE ROLE OF AZACITIDINE IN THE TREATMENT OF ELDERLY PATIENTS WITH AML - 
    Tombak, A; Ucar, MA; Akdeniz, A; Tiftik, EN; Sahin, D; Akay, OM; Yildirim, M; Nevruz, O; Kis, C; Gurkan, E; Solmaz, SM; Ozcan, MA; Yildirim, R; Berber, I; Erkurt, MA; Tuglular, TF; Tarkun, P; Yavasoglulo, I; Dogu, MN; Sari, I; Merter, M; Ozcan, M; Yildizhan, E; Kaynar, L; Mehtap, O; Uysal, A; Sahin, F; Salim, O; Sungur, MA (2015)
  • The Role of Azacitidine in the Treatment of Elderly Patients with Acute 
    Tombak, A; Ucar, MA; Akdeniz, A; Tiftik, EN; Sahin, DG; Akay, OM; Yildirim, M; Nevruz, O; Kis, C; Gurkan, E; Solmaz, SM; Ozcan, MA; Yildirim, R; Berber, I; Erkurt, MA; Tuglular, TF; Tarkun, P; Yavasoglu, I; Dogu, MH; Sari, I; Merter, M; Ozcan, M; Yildizhan, E; Kaynar, L; Mehtap, O; Uysal, A; Sahin, F; Salim, O; Sungur, MA (2016)
    Objective: In this study, we aimed to investigate the efficacy and safety of azacitidine (AZA) in elderly patients with acute myeloid leukemia (AML), including patients with >30% bone marrow (BM) blasts.
  • Efficacy and Safety of Ibrutinib Use in Patients with Chronic 
    Tombak, A; Tanrikulu, FP; Durusoy, SS; Gurkan, E; Kaya, E; Umit, EG; Yavasoglu, I; Mehtap, O; Deveci, B; Ozcan, MA; Terzi, H; Okay, M; Sayinalp, N; Yilmaz, M; Okan, V; Kizikli, A; Ozcan, O; Cetin, G; Demircioglu, S; Aydogdu, I; Saydam, G; Davulcu, EA; Ilhan, G; Ucar, MA; Ozet, G; Akpinar, S; Turgut, B; Berber, I; Kurtoglu, E; Sonmez, M; Batur, DS; Yildirim, R; Ozkocaman, V; Gunes, AK; Sahip, B; Ertop, S; Akay, M; Basturk, A; Dogu, MH; Akdeniz, A; Unal, A; Seyhanli, A; Ferhanoglu, B (2019)
  • Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic 
    Tombak, A; Tanrikulu, FP; Durusoy, SS; Dincyurek, HD; Kaya, E; Umit, EG; Yavasoglu, I; Mehtap, O; Deveci, B; Ozcan, MA; Terzi, H; Okay, M; Sayinalp, N; Yilmaz, M; Okan, V; Kizikli, A; Ozcan, O; Cetin, G; Demircioglu, S; Aydogdu, I; Saydam, G; Davulcu, EA; Ilhan, G; Ucar, MA; Ozet, G; Akpinar, S; Turgut, B; Berber, I; Kurtoglu, E; Sonmez, M; Batur, DS; Yildirim, R; Ozkocamaz, V; Gunes, AK; Sahip, B; Ertop, S; Akay, OM; Basturk, A; Dogu, MH; Akdeniz, A; Unal, A; Seyhanli, A; Gurkan, E; Cekdemir, D; Ferhanoglu, B (2021)
    Objective: This study aimed to retrospectively evaluate the efficacy, safety, and survival outcome of single-agent ibrutinib therapy in chronic lymphocytic leukemia patients. Materials and Methods: A total of 136 patients ...
  • Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic 
    Tombak, A; Tanrikulu, FP; Durusoy, SS; Dincyurek, HD; Kaya, E; Umit, EG; Yavasoglu, I; Mehtap, O; Deveci, B; Ozcan, MA; Terzi, H; Okay, M; Sayinalp, N; Yilmaz, M; Okan, V; Kizikli, A; Ozcan, O; Cetin, G; Demircioglu, S; Aydogdu, I; Saydam, G; Davulcu, EA; Ilhan, G; Ucar, MA; Ozet, G; Akpinar, S; Turgut, B; Berber, I; Kurtoglu, E; Sonmez, M; Batur, DS; Yildirim, R; Ozkocamaz, V; Gunes, AK; Sahip, B; Ertop, S; Akay, OM; Basturk, A; Dogu, MH; Akdeniz, A; Unal, A; Seyhanli, A; Gurkan, E; Cekdemir, D; Ferhanoglu, B (2021)
    Objective: This study aimed to retrospectively evaluate the efficacy, safety, and survival outcome of single-agent ibrutinib therapy in chronic lymphocytic leukemia patients. Materials and Methods: A total of 136 patients ...